Medicare Enrolled
Dr. Mark Saltzman, MD
Interventional Cardiology · Boca Raton, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Saltzman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Saltzman? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Saltzman
Dr. Mark Saltzman is an interventional cardiology in Boca Raton, FL, with 20 years in practice. Based on federal Medicare data, Dr. Saltzman performed 15,207 Medicare services across 9,636 unique beneficiaries.
Between the years covered by Open Payments, Dr. Saltzman received a total of $11,187 from 51 pharmaceutical and/or device companies across 561 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Saltzman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 2% volume in FL$ $11,187 industry payments
Medicare Practice Summary
Medicare Utilization ↗15,207
Medicare services
Top 2% in FL for interventional cardiology
9,636
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~760 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,712 | $95 | $140 |
| Blood draw (venipuncture) | 1,211 | $7 | $7 |
| Electrocardiogram (EKG), 12-lead | 1,104 | $11 | $55 |
| Office visit, established patient (20-29 min) | 850 | $66 | $100 |
| Comprehensive metabolic blood panel | 797 | $10 | $72 |
| Creatine kinase (cardiac enzyme) level, total | 772 | $6 | $12 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 740 | $28 | $45 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 730 | $20 | $96 |
| Hemoglobin A1c test (diabetes monitoring) | 620 | $10 | $28 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 574 | $88 | $300 |
| Echocardiogram, transthoracic | 567 | $146 | $850 |
| Regadenoson injection (Lexiscan) for heart stress test | 498 | $44 | $80 |
| Lipid panel (cholesterol and triglycerides) | 424 | $13 | $27 |
| Complete blood count (CBC) with differential | 384 | $8 | $25 |
| Hospital follow-up visit, high complexity | 317 | $97 | $145 |
| Ldl cholesterol level | 316 | $10 | $20 |
| EKG interpretation and report | 297 | $7 | $9 |
| Basic metabolic blood panel | 289 | $8 | $22 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 288 | $49 | $300 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 287 | $342 | $1,140 |
| Infusion, normal saline solution, 250 cc | 287 | $1 | $15 |
| Natriuretic peptide (heart and blood vessel protein) level | 280 | $38 | $70 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 216 | $17 | $35 |
| Magnesium level test | 204 | $7 | $15 |
| Thyroid stimulating hormone (TSH) test | 174 | $16 | $40 |
| Remote pacemaker/defibrillator monitoring, 90 days | 173 | $17 | $50 |
| Remote pacemaker monitoring, 90 days | 170 | $23 | $50 |
| Thyroid hormone evaluation | 163 | $6 | $15 |
| Thyroxine (thyroid chemical), total | 162 | $7 | $15 |
| Initial hospital admission, high complexity | 140 | $141 | $260 |
| New patient office visit, complex (60-74 min) | 128 | $161 | $250 |
| Programming of dual lead pacemaker system | 71 | $25 | $65 |
| Hospital follow-up visit, moderate complexity | 53 | $65 | $120 |
| Insertion of heart rhythm monitor under skin | 37 | $3,472 | $6,500 |
| Ultrasound of both sides of head and neck blood flow | 36 | $115 | $247 |
| Ultrasound of heart, follow-up | 33 | $72 | $230 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 31 | $19 | $50 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 28 | $2 | $35 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 19 | $21 | $50 |
| Urinalysis, manual | 14 | $3 | $10 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 11 | $4 | $12 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.5% high complexity
7.5% medium
84.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,187
Total received (2018-2024)
Avg $1,598/year across 7 years
Top 43% in FL for interventional cardiology
51
Companies
561
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,970 (98.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$217 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,876
2023$2,410
2022$1,741
2021$701
2020$648
2019$1,614
2018$2,196
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$1,641
Amgen Inc.
$1,297
Novartis Pharmaceuticals Corporation
$1,265
Boehringer Ingelheim Pharmaceuticals, Inc.
$832
PFIZER INC.
$745
Janssen Pharmaceuticals, Inc
$506
Philips Electronics North America Corporation
$438
AstraZeneca Pharmaceuticals LP
$395
E.R. Squibb & Sons, L.L.C.
$371
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$362
SANOFI-AVENTIS U.S. LLC
$358
Astellas Pharma US Inc
$272
Boston Scientific Corporation
$249
Merck Sharp & Dohme LLC
$232
Cardiovascular Systems Inc.
$162
ATRICURE, INC.
$161
Alnylam Pharmaceuticals Inc.
$151
AtriCure, Inc.
$150
Regeneron Healthcare Solutions, Inc.
$129
Philips North America LLC
$125
Kiniksa Pharmaceuticals, Ltd.
$122
Welch Allyn
$108
Kowa Pharmaceuticals America, Inc.
$89
Kiniksa Pharmaceuticals International, plc
$83
Amarin Pharma Inc.
$75
Kestra Medical Technology Services, Inc.
$67
ABIOMED
$63
Merck Sharp & Dohme Corporation
$58
Medtronic Vascular, Inc.
$58
Biosense Webster, Inc.
$57
Edwards Lifesciences Corporation
$50
Medtronic, Inc.
$48
PORTOLA PHARMACEUTICALS, INC.
$48
Bayer Healthcare Pharmaceuticals Inc.
$48
Esperion Therapeutics, Inc.
$46
Allergan Inc.
$37
CARDIVA MEDICAL, INC.
$29
Gilead Sciences, Inc.
$28
HEARTFLOW, INC.
$26
AGEPHA Pharma FZ LLC
$25
Lexicon Pharmaceuticals, Inc.
$24
Silk Road Medical, Inc.
$19
Lundbeck LLC
$18
CHIESI USA, INC.
$18
Akcea Therapeutics, Inc.
$16
Chiesi USA, Inc.
$16
ARBOR PHARMACEUTICALS, INC.
$15
BOSTON SCIENTIFIC CORPORATION
$15
Shockwave Medical, Inc
$13
ACIST MEDICAL SYSTEMS, INC.
$12
HeartFlow, Inc.
$12
Top 3 companies account for 37.6% of total payments
Associated products mentioned in payments ›
(5044) MCOT · (5091) Amb Mon & Diag Und · (7999) SRC Undivided · (CM9) Amb Mon & Diag Und · ATRICURE CRYOSURGICAL SYSTEM · AVEIR · Advisa · Arcalyst · Asahi Fielder coronary guide wire · Assure WCD · Assurity Pacemaker · BEVYXXA · BRILINTA · BYSTOLIC · CAMZYOS · CARDIVA VASCADE 6/7F VCS · CARTO 3 · CLEVIPREX 50MG/100ML · CONFIRM RX · CVI SYSTEMS · Confirm Rx · Connectivity and Remote care · Corlanor · Coronary Orbital Atherectomy System · ELIQUIS · ENROUTE Transcarotid Neuroprotection System · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYS · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edarbi · Evera · FARXIGA · FFRct · GALLANT · General - Therapies · Impella · Inpefa · JARDIANCE · JOT DX · KENGREAL · Kerendia · LEQVIO · LEXISCAN · LIVALO · LODOCO · LUX-Dx Insertable Cardiac Monitor · Lexiscan · LifeVest · Livalo · MERLIN@HOME · MICRA · MITRACLIP · MULTAQ · Merlin Connectivity and Remote · Mitra Clip system · NA · NEXLETOL · NORTHERA · ONPATTRO · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Peripheral Orbital Atherectomy System · QUADRA ALLURE MP · Repatha · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · TEGSEDI · VERQUVO · VYNDAMAX · VYNDAQEL · Vascepa · Visia AF · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · Xience cornary stent systems
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $74 per 100 Medicare services performed
Geographic Context
Interventional Cardiologys within 10 mi
32
Per 100K population
2.1
County median income
$81,115
Nearest hospital
BOCA RATON REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Saltzman is a clinical cardiology specialist, with above-average Medicare volume (top 2% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Saltzman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Saltzman performed 1,712 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Saltzman receive payments from pharmaceutical companies?
Yes. Dr. Saltzman received a total of $11,187 from 51 companies across 561 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Saltzman's costs compare to other interventional cardiologys in Boca Raton?
Dr. Saltzman's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Saltzman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologys in Boca Raton
Browse interventional cardiologys in Boca Raton ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologys in FL
Interventional Cardiologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologys in FL
Which FL interventional cardiologys receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology